We are live on ! Find out more
JMPWA

JP Morgan Private Wealth Advisors Portfolio holdings

AUM $35B
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+24.26%
3 Year Est. Return
+44.77%
5 Year Est. Return
+86.56%
10 Year Est. Return
+266.4%
AUM
$46.5B
AUM Growth
+$5.62B
Cap. Flow
+$1.88B
Cap. Flow %
4.04%
Top 10 Hldgs %
22.88%
Holding
2,079
New
143
Increased
1,062
Reduced
697
Closed
96

Sector Composition

Rank Sector Weight
1 Technology 18.82%
2 Financials 9.82%
3 Healthcare 8.54%
4 Consumer Discretionary 8.23%
5 Industrials 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWP
1951
abrdn Global Premier Properties Fund
AWP
$360M
$73K ﹤0.01%
+3,533
New +$68.3K
TME icon
1952
Tencent Music
TME
$14.3B
$73K ﹤0.01%
10,648
-152
-1% -$1.12K
FEMY icon
1953
Femasys
FEMY
$7.1M
$71K ﹤0.01%
+914
New +$106K
DM
1954
DELISTED
Desktop Metal, Inc.
DM
$69K ﹤0.01%
1,404
-316
-18% -$21.3K
MAPSW
1955
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$67K ﹤0.01%
+50,000
New +$142K
EDU icon
1956
New Oriental
EDU
$8.82B
$62K ﹤0.01%
2,969
-256
-8% -$5.52K
LOGC
1957
DELISTED
ContextLogic
LOGC
$58K ﹤0.01%
+625
New +$82.9K
VYNT
1958
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$55K ﹤0.01%
8,202
DFTX
1959
Definium Therapeutics
DFTX
$5.48B
$52K ﹤0.01%
2,500
-322
-11% -$10.3K
BKCC
1960
DELISTED
BlackRock Capital Investment Corporation
BKCC
$40K ﹤0.01%
10,000
MTNB icon
1961
Matinas BioPharma
MTNB
$1.66M
$32K ﹤0.01%
634
HIPO icon
1962
Hippo Holdings
HIPO
$864M
$29K ﹤0.01%
404
-84
-17% -$7.83K
ADVM
1963
DELISTED
Adverum Biotechnologies
ADVM
$28K ﹤0.01%
1,617
-900
-36% -$18K
HCARW
1964
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$26K ﹤0.01%
49,998
ATOS icon
1965
Atossa Therapeutics
ATOS
$23.1M
$22K ﹤0.01%
933
+200
+27% +$7.32K
PULM icon
1966
Pulmatrix
PULM
$5.77M
$22K ﹤0.01%
2,500
UAVS icon
1967
AgEagle Aerial Systems
UAVS
$58.6M
$22K ﹤0.01%
14
+4
+40% +$9.69K
DNA.WS
1968
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$22K ﹤0.01%
10,000
BBGI icon
1969
Beasley Broadcasting Group
BBGI
$40.7M
$21K ﹤0.01%
563
BTOG icon
1970
Bit Origin
BTOG
$2.32M
$21K ﹤0.01%
+8
New +$21.5K
SUPV
1971
Grupo Supervielle
SUPV
$740M
$21K ﹤0.01%
+11,000
New +$23.5K
ALPP
1972
DELISTED
Alpine 4 Holdings Inc
ALPP
$19K ﹤0.01%
+1,250
New +$27.8K
DPRO
1973
Draganfly
DPRO
$164M
$18K ﹤0.01%
+440
New +$31.2K
GPUS
1974
Hyperscale Data Inc
GPUS
$55.4M
0
XBIO icon
1975
Xenetic Biosciences
XBIO
$7.26M
$13K ﹤0.01%
+1,000
New +$16K

Similar funds

JP Morgan Private Wealth Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, JP Morgan Private Wealth Advisors held 2,079 positions worth $46.5B, up 14% from $40.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

JP Morgan Private Wealth Advisors deployed $1.88B of net new capital in Q4 2021, opening 143 new positions and adding to 1,062 existing holdings. Its largest new stake was Coterra Energy: 656,355 shares worth $12.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Teladoc Health, an estimated $50.7M trimmed.

  • JP Morgan Private Wealth Advisors's largest Q4 2021 buy was Coterra Energy: 656,355 shares worth $12.5M.
  • JP Morgan Private Wealth Advisors added most to Airbnb in Q4 2021, an estimated $255M increase.
  • JP Morgan Private Wealth Advisors's biggest Q4 2021 reduction was Teladoc Health, cutting an estimated $50.7M.
  • JP Morgan Private Wealth Advisors fully exited Apollo Global Management in Q4 2021, selling an estimated $82.6M.
  • JP Morgan Private Wealth Advisors's ten largest holdings make up 23% of its $46.5B portfolio in Q4 2021.
  • JP Morgan Private Wealth Advisors opened 143 new positions and closed 96 in Q4 2021.
  • JP Morgan Private Wealth Advisors's portfolio value rose 14% quarter-over-quarter to $46.5B.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.